Previous studies have suggested an association of hyperhomocysteinemia-induced vascular pathology with enhanced apoptotic potential of endothelial progenitor cells in patients with coronary heart disease. Our results indicate that 500 mol/L homocysteine induced endothelial progenitor cell apoptosis and activation of caspase-3, both of which were abolished by 100 mol/L and 200 mol/L salubrinal, an agent that prevents endoplasmic reticulum stress-induced apoptosis. The addition of 500 mol/L homocysteine caused a release of Ca 2þ from intracellular stores, and enhanced phosphor-eukaryotic initiation factor 2 phosphorylation at Ser51 and the expression of a glucose-regulated protein of 78 kDa and a C/EBP homologous protein independently of extracellular Ca 2þ . These effects of homocysteine on endothelial progenitor cells were significantly greater in patients with coronary heart disease than in healthy donors. These findings suggest that homocysteine induces endoplasmic reticulum stress-mediated activation of caspase-3 in endothelial progenitor cells, an event that is enhanced in patients with coronary heart disease. Furthermore, enhanced endoplasmic reticulum stress-mediated activation of caspase-3 in endothelial progenitor cells might be involved in hyperhomocysteinemia-associated vascular pathology.
Previous studies have suggested an association of hyperhomocysteinemia-induced vascular pathology with enhanced apoptotic potential of endothelial progenitor cells in patients with coronary heart disease. Our results indicate that 500 mol/L homocysteine induced endothelial progenitor cell apoptosis and activation of caspase-3, both of which were abolished by 100 mol/L and 200 mol/L salubrinal, an agent that prevents endoplasmic reticulum stress-induced apoptosis. The addition of 500 mol/L homocysteine caused a release of Ca 2þ from intracellular stores, and enhanced phosphor-eukaryotic initiation factor 2 phosphorylation at Ser51 and the expression of a glucose-regulated protein of 78 kDa and a C/EBP homologous protein independently of extracellular Ca 2þ . These effects of homocysteine on endothelial progenitor cells were significantly greater in patients with coronary heart disease than in healthy donors. These findings suggest that homocysteine induces endoplasmic reticulum stress-mediated activation of caspase-3 in endothelial progenitor cells, an event that is enhanced in patients with coronary heart disease. Furthermore, enhanced endoplasmic reticulum stress-mediated activation of caspase-3 in endothelial progenitor cells might be involved in hyperhomocysteinemia-associated vascular pathology.
Key words: homocysteine; endothelial progenitor cells; apoptosis; endoplasmic reticulum stress It is generally recognized that hyperhomocysteinemia (HHcy) is an important risk factor for coronary artery disease (CAD), 1) but the pathogenesis of its vascular action remains to be elucidated. Accumulating evidence has demonstrated that endothelial dysfunction plays a major role in HHcy-related vascular pathology.
2) Endothelial dysfunction is a loss of balance between injury and repair capacity. Recent studies suggest an important role of endothelial progenitor cells (EPCs) in endothelial repair after injury.
3) CAD Patients have decreased numbers of EPCs with impaired functional capacity. 4) In vitro, homocysteine (Hcy) dose-and time-dependently decreases EPC numbers and impairs cell proliferation, migration, and vasculogenesis capacity. 5) Impaired EPC numbers and functional capacity have been identified in a murine model with HHcy. 6) One possible explanation for the reduced capacity of EPCs is increased apoptosis of premature progenitor cells. Recently, Bao found that Hcy induces apoptosis of EPCs in vitro.
7)
Taken together, these findings suggest an association of Hcy with the enhanced apoptotic potential of EPCs in CAD patients.
The endoplasmic reticulum (ER) has a high sensitivity to alteration in Ca 2þ homeostasis, and a low luminal Ca 2þ concentration ([Ca 2þ ] ER ) leads to oxidative stress and the accumulation of misfolded or unfolded proteins, resulting in ER dysfunction and stress. 8) ER stress is triggered by an accumulation of misfolded proteins in the ER that bind to an ER chaperone glucose-regulated protein of 78 kDa (Grp78). This causes the unfolded protein response (UPR), resulting in the dissociation of Grp78 from the three major ER stress sensors: protein kinase RNA-like ER kinase (PERK), activating transcription factor-6 (ATF6), and inositol-requiring protein-1 (IRE-1).
9) PERK-dependent phosphorylation of eukaryotic initiation factor 2 (eIF2) results in translational attenuation, reducing the load of new protein synthesis on the ER. These responses re-establish homeostasis and normal ER function. If ER stress is severe or prolonged, apoptotic cell death is induced. 8) Several apoptosis pathways are known to be involved, the central role being played by the proapoptotic transcription factor C/EBP homologous protein (CHOP). 8) Transcriptional induction of CHOP depends mostly on activation of PERK/ eIF2. ER stress has been found to be involved in endothelial dysfunction and related vascular pathologies. Upregulation of Grp78 and other ER stress-related genes was detected in a murine model of myocardial infarction. 9) Both cytoprotective and apoptotic components of ER stress signaling are upregulated in heart failure. High levels of apoptosis and of the expression of Grp78 and CHOP were found within fibrous caps of atheroma and ruptured plaques of both autoptic human coronary specimens and atherectomy specimens from patients with unstable angina pectoris. 10) A previous report provided evidence of the relevance of ER stress to macrophage apoptosis and enlargement of the necrotic core in advanced athero- Hcy is a well-known inducer of ER stress. Apolipoprotein E-deficient mice fed a HHcy diet exhibit increased expression of molecular markers of ER stress in both early and late atherosclerotic lesions. 13) In a rat model of HHcy, increased expression of ER stressassociated proteins, including Grp78, CHOP, and caspase-12, was found in myocardial tissue. 14) In vitro, Hcy induces ER stress and cell apoptosis in cardiomyocytes, 14) smooth muscle cells, 15) and endothelial cells. 16) Although these studies indicate that Hcy is closely associated with ER stress-mediated cell apoptosis, it is yet not clear whether ER stress contributes to HHcyrelated vascular pathology, or how this might occur. Hence, we investigated the possible role of Hcy in ER stress-mediated apoptosis in EPCs from CAD patients and healthy donors in an attempt to elucidate the mechanisms underlying HHcy-related vascular pathology associated with CAD.
Materials and Methods
Materials. EGM-2 endothelial medium and EGM-2-MV-SingleQuots were purchased from Clonetics (San Diego, CA). Fura-2 AM, fura-FF AM, and pluronic acid were from Molecular Probes (Leiden, Netherlands). Hcy, fibronectin (FN), thapsigargin (TG), ionomycin, 1,2-bis(o-aminophenoxy)ethane-N,N,N 0 ,N 0 -tetraacetic acid (BATPA), and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody were from Sigma-Aldrich (St. Louis, MO). Salubrinal was from Tocris (Bristol, UK). Anti-Grp78 and -phospho-eIF2 (Ser51) antibodies were from Cell Signaling Technology (Danvers, MA). Anti-CHOP antibody and horseradish peroxidase-conjugated secondary IgG antibody were from Santa Cruz Biotechnology (Santa Cruz, CA). Other reagents are indicated below. Isolation, incubation, and identification of EPCs. EPCs were prepared as described previously. 5) Briefly, mononuclear cells were isolated from peripheral blood by Ficoll density gradient centrifugation and cultured on human FN-coated dishes in EGM-2 endothelial medium supplemented with EGM-2-MV-SingleQuots and 20% FBS.
Cellular apoptosis detected by flow cytometer. EPCs were seeded and pre-cultured at 37 C for 24 h. After treatment with various drugs for various durations, EPCs were collected and treated according to the protocol in the Annexin V-FITC Apoptosis Detection Kit (Merck, Germany). The percentages of apoptotic cells were determined with a FACSCalibur flow cytometer with CellQuest software (BD Pharmingen, San Diego, CA).
Measurement of caspase-3 activity. The activity of caspase-3 was evaluated using a colorimetric activity assay kit (Chemicon International Molecular, Temecula, CA) following the manufacturer's instructions. Briefly, the cells were lysed for 30 min on an ice bath. The lysed cells were centrifuged at 12;000 Â g for 10 min. After the protein concentration was determined, 100 mg of the protein was incubated with 50 mL of a reaction buffer and 5 mL of the caspase-3 substrate (Ac-DEVD-pNA) on a 96-well plate. The activity of caspase-3 was measured using a spectrophotometer at 405 nm, and the results were expressed as fold increase over mean value of the control. . Endothelial progenitor cells were incubated with 5 mmol/L of fura-FF AM for 1 h in the presence of 0.025% pluronic acid, and were loaded with 10 mmol/L dimethyl BATPA for 30 min. EPCs were then collected by centrifugation at 1;000 Â g for 10 min and resuspended in HEPES-buffered saline. Fluorescence was recorded from 1 mL aliquots of magnetically stirred cell suspensions (10 8 cells/mL) at 37 C using a spectrophotometer (Zeiss) with ex 340 nm and em 505 nm. Changes in [Ca 2þ ] ER were expressed as F n /F 0 , considering F 0 as fluorescence of fura-FF in the absence of free Ca 2þ .
Measurement
Immunoblotting. Following treatment, whole-cell lysates were prepared as described previously. 17) In some experiments, immunoblotting for CHOP protein was additionally performed on nuclear extracts prepared using a Nuclear Extraction Kit following the manufacturer's protocol (Millipore, Billerica, MA). The protein concentration was determined by the Lowry method. Ten mL of protein was loaded in each lane and subjected to SDS-PAGE (8%), and then transferred to a polyvinylidene difluoride (PVDF) membrane. The blots were probed with antibodies against phospho-eIF2, Grp78, CHOP, or GAPDH. Horseradish peroxidase-conjugated secondary antibodies were used in conjunction with an ECL chemiluminescence detection system (Roche, Mannheim, Germany) and quantified by scanning densitometry.
Statistical analysis. All data are presented as mean AE SEM. Statistical evaluation of the data was performed by Student's t test for paired or unpaired observations and by analysis of variance (ANOVA). Scheffe's test for multiple comparisons was used to identify differences among groups. Values were considered to be significantly different at p < 0:05.
Results

Comparison of the numbers of EPCs from CAD patients and healthy donors
Approximately 5 Â 10 6 mononuclear cells from every CAD patient and healthy control were seeded. The number of EPCs was significantly higher (0:064 AE 0:004) in the CAD patients than in the healthy controls (0:032 AE 0:004; p < 0:01, n ¼ 12 in each group) (Fig. 1) .
Comparison of apoptosis of EPCs induced by Hcy from CAD patients and healthy donors
The apoptosis of EPCs induced by Hcy was examined in the presence of various concentrations of Hcy (0, 50, 100, and 500 mmol/L) over 24 h and in the presence of 500 mmol/L Hcy for 0, 12 h, 24 h, and 48 h. As shown in Fig. 2, after 24 h Hcy induced a detectable increase in the percentage of apoptotic EPCs with 100 mmol/L to 3:8 AE 0:8% and 5:1 AE 0:9% in healthy donors and CAD patients respectively, with a maximal effect at 500 mmol/L (7:4 AE 1:2% vs. 8:2 AE 0:8%, p < 0:05), and also after 48 h of treatment (13:7 AE 1:3% vs. 15:9 AE 0:9%, p < 0:05) in healthy donors and CAD patients.
Hcy induced ER-dependent caspase-3 activation in EPCs from CAD patients and healthy donors
Caspase-3 activation of EPCs induced by Hcy was examined in the presence of various concentrations of Hcy (0, 50, 100, and 500 mmol/L) for 24 h and in the presence of 500 mmol/L Hcy for 0, 12 h, 24 h, and 48 h. Hcy induced caspase-3 activity in a dose-and timedependent manner in healthy donors and CAD patients, with a maximal effect at 500 mmol/L (3:8 AE 0:5-and 4:7 AE 0:4-fold increases vs. control untreated cells; p < 0:05, n ¼ 6 in each group) and after 48 h of treatment (4:8 AE 0:5-and 5:7 AE 0:4-fold increases vs. untreated cells; p < 0:05, n ¼ 6 in each group) (Fig. 3A  and B) .
To determine whether the caspase-3 activation induced by Hcy is a result of endoplasmic reticulum stress, we used salubrinal, a cell-permeant, selective inhibitor of eIF2 dephosphorylation that protects cells from endoplasmic reticulum stress. 18) EPCs from healthy donors and CAD donors were stimulated with Hcy (500 mmol/L) after pretreatment with various concentrations of salubrinal (10, 100, and 200 mmol/L) for 30 min. The Hcy-evoked increase in caspase-3 activity was inhibited by pretreatment with salubrinal in both CAD patients and healthy donors, with a maximum effect at 200 mmol/L, with 1:3 AE 0:5-and 1:6 AE 0:4-fold increases vs. control (untreated cells) in healthy donors and CAD patients respectively (p < 0:05, n ¼ 6 in each group) (Fig. 3C) . Figure 3D shows that salubrinal inhibited Hcy-induced apoptosis of EPCs from healthy donors and CAD patients.
Hcy mobilized Ca
2þ from intracellular pools The intracellular free calcium concentration and [Ca 2þ ] ER were measured in the presence of 50, 100, and 500 mmol/L Hcy. In a Ca 2þ -free medium, treatment of fura-2-loaded EPCs with Hcy induced a dosedependent increase in cytosolic Ca 2þ due to Ca 2þ release from intracellular Ca 2þ compartments. Cytosolic Ca 2þ concentrations, both at rest and after stimulation with Hcy, were significantly greater in CAD patients than in healthy donors (Fig. 4A-D) . To investigate further the ability of Hcy to release Ca 2þ from intracellular stores, EPCs were loaded with fura-FF, a common tool to measure compartmentalized Ca 2þ . In addition, cells were loaded with dimethyl BAPTA and suspended in a Ca 2þ -free medium (100 mmol/L EGTA added) to avoid interference with cytosolic and with extracellular Ca 2þ respectively. As shown in Fig. 4E, Hcy (0, 50, 100 , and 500 mmol/L) decreased [Ca 2þ ] ER due to Ca 2þ release in a dosedependent manner. The Ca 2þ remaining in the stores after 10 min of treatment with Hcy was estimated by the addition of TG (1 mmol/L), an inhibitor of sarcoendoplasmic Ca 2þ ATPase, in combination with ionomycin (50 nmol/L), to deplete the intracellular Ca 2þ stores fully (Fig. 4F) . 
Hcy induced UPR activation in EPCs from CAD patients and healthy donors
Since Hcy induces Ca 2þ efflux from intracellular stores, which can induce ER stress, UPR activation was detected by immunoblotting using specific anti-phospho-eIF2 and anti-Grp78 antibodies. As shown in Fig. 5A and B, in a Ca 2þ -free medium, Hcy (500 mmol/L) induced time-dependent phosphorylation of eIF2 and expression of Grp78. These were significantly greater in the EPCs from the CAD patients than from the healthy donors. The maximal effect of Hcy was obtained after 48 h of treatment in CAD patients and healthy donors. In a medium containing 1 mmol/L of Ca 2þ , similar results were obtained for the phosphorylation of eIF2 and the expression of Grp78 (data not shown).
Since prolonged or severe ER stress is linked to the triggering of programmed cell death, the effect of Hcy on CHOP, a major ER stress-inducible pro-apoptotic transcription factor that operates as a downstream component of the ER-stress pathway, was investigated. We found that CHOP expression increased after treatment with Hcy (500 mmol/L) for various times (0, 12, 24, and 48 h). Maximum CHOP expression was obtained at 48 h of exposure to Hcy (Fig. 5C) . In a medium containing 1 mmol/L of Ca 2þ , similar results were obtained for the expression of CHOP (data not shown).
Discussion
In this study, we confirmed the observations of Bao 7) and Alam, 19) who reported that Hcy induces apoptosis of peripheral EPCs in vitro. We report for the first time that the Hcy-induced apoptotic potential of EPCs from patients with CAD was higher than that from healthy donors. Furthermore, Hcy-induced EPC apoptosis was operational via ER stress-mediated caspase-3 activation.
Patients with CAD show decreased numbers of EPCs with impaired functions, which can be due to several mechanisms such as calcium signaling and oxidative stress. The imbalance between oxygen radical generation and antioxidant power plays an important role in the pathogenesis of Hcy-related vascular pathology, and oxidative stress has been found to be involved in the development of vascular and blood cell apoptosis, including EPCs. 7) We report for the first time that Hcy induced ER stress in EPCs, independently of extracellular Ca 2þ levels, by promoting Ca 2þ efflux from intracellular stores. The mechanism underlying Ca 2þ release from intracellular stores by Hcy was not further investigated, but it is probably attributable to the oxidant actions of Hcy. Oxygen radicals have been reported to induce Ca 2þ release in various cell types, including endothelial cells, 20) smooth muscle cells, 21) and cardiomyocytes. EPCs from healthy donors and CAD patients were treated in a Ca 2þ -free medium with 500 mmol/L of Hcy for various durations, and eIF2 phosphorylation and Grp78 and CHOP expression were determined by immunoblotting. GAPDH was assayed to verify equal loading of cell lysates. The left panels show representative immunoblots, indicating that Hcy induced eIF2 phosphorylation and Grp78 and CHOP expression in a time-dependent manner. The three right panels show quantification of the bands by densitometry. Results are normalized to the levels of GAPDH and are shown as percentages of untreated control cells from four independent experiments. Ã p < 0:05 as compared with healthy donors.
In our study, Hcy enhanced phosphorylation of eIF2 at Ser, and increased the expression of Grp78 and CHOP in a time-dependent manner. Other ER stress activators, such as TG can increase Grp78 and CHOP, confirming the ability of Hcy to induce ER stress in EPCs. ER stress has been suggested to lead to the activation of certain caspases, including caspase-3, caspase-4, and caspase-9. 23) We found that Hcy caused time-and dose-dependent activation of caspase-3. The activation of caspase-3 is probably attributable to ER stress, since salubrinal, a cell-permeant inhibitor of eIF2 phosphatase at Ser, prevented the caspase-3 activation induced by Hcy. However, another mechanism might be involved in Hcyinduced caspase-3 activation. Alam et al. reported that Hcy induces apoptosis in EPCs through the mitochondrial pathway. 19) We found that high concentrations of Hcy induced greater survival/rescue molecules, phosphorylated eIF2 and Grp78 expression, and apoptotic molecules, and enhanced CHOP and activated caspase-3 expression in peripheral EPCs from CAD patients. These findings might be explained by a loss of efficiency of the UPR due to UPR dysfunction induced by Hcy. UPR dysfunction has been found in a number of disorders, including non-alcoholic fatty liver disease, 24) renal disorders, 25) and diabetes mellitus. Additional evidence suggests that ER stress and UPR dysfunction play important roles in the pathogenesis of atherosclerosis, contributing to endothelium dysfunction. 26) Here we report for the first time that there was UPR dysfunction in CAD. Our finding that Hcy-induced EPC actions, including Ca 2þ mobilization, eIF2 phosphorylation, Grp78 and CHOP expression, and caspase-3 activation, were significantly greater in patients with CAD than in healthy donors, suggests that Hcy is more efficient at inducing EPC effects in CAD patients than in healthy donors. Taken together with the reported higher Hcy levels in CAD patients, these findings suggest that plasma Hcy plays an important role in the pathogenesis of HHcy-related vascular pathology. Our results indicate that ER stress, and subsequently eIF2 phosphorylation and Grp78 and CHOP expression, were similar in EPCs from healthy donors and CAD patients at rest. This might be because, despite the finding that resting [Ca 2þ ] c in EPCs from CAD patients was enhanced as compared with healthy controls, the amount of Ca 2þ accumulated in the stores was comparable in the EPCs from CAD patients and healthy donors. Thus, the ER stress level at rest was comparable in the EPCs from CAD patients and healthy donors.
In summary, our results indicate for the first time that the Hcy-induced apoptotic potential of EPCs from CAD patients is greater than that from healthy donors. Furthermore, Hcy-induced EPCs apoptosis is operational via ER stress-induced caspase-3 activation. The EPCs from CAD patients showed a higher sensitivity to Hcy than those from healthy donors. These findings provide evidence of a new mechanism underlying Hcyinduced apoptosis that might be involved in the pathogenesis of HHcy-related vascular pathology.
